On the anti-correlation between COVID-19 infection rate and natural UV light in the UK

Arnon Blum; Constantina Nicolaou; Ben Henghes; Ofer Lahav

doi:10.1101/2020.11.28.20240242

Abstract

While it is well established that the rate of COVID-19 infections can be suppressed by social distancing, environmental effects may also affect the infection rate. Here we consider the hypothesis that natural Ultra-Violet (UV) light (UVA and UVB) is reducing COVID-19 infections by enhancing human immunity through vitamin-D and/or by suppressing the virus itself. We focus on the United Kingdom (UK), by examining daily COVID-19 infections (F) and UV Index (UVI) data over the period March to October 2020. We find an intriguing empirical anti-correlation between log₁₀(F) and log₁₀(UVI) with a correlation coefficient of -0.933 over the period from 11 May (when the first UK lockdown ended) to 28 October 2020. The anticorrelation may reflect causation with other factors which are correlated with the UVI. Either way, UVI should be included in modelling the pattern of COVID-19 infections and deaths. We started quantifying such correlations in other countries and regions.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

BH, OL and CN are supported by the STFC UCL Centre for Doctoral Training in Data Intensive Science (grant number ST/P006736/1).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

N/A

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

We use publicly available data from JHU on COVID-19 and from TEMIS on UVI.

The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.